Gabelli & Co Investment Advisers’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-347,727	Closed	-$16.7M	–	213
2020 Q1	$16.7M	Sell	347,727 -13,720	-4%	-$638K	2.51%	12
2019 Q4	$17M	Buy	+361,447	New	+$16M	1.96%	15

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Gabelli & Co Investment Advisers's RARX Position: Q2 2020 in Review

Gabelli & Co Investment Advisers sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 347,727 shares — an estimated $16.7M sold.

Gabelli & Co Investment Advisers first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $17M in Q4 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Gabelli & Co Investment Advisers reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 347,727 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $16.7M.
Gabelli & Co Investment Advisers first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
Gabelli & Co Investment Advisers's Ra Pharmaceuticals, Inc. Common Stock position peaked at $17M in Q4 2019.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.